AcelRx Pharmaceuticals, Inc. (ACRX) financial statements (2022 and earlier)

Company profile

Business Address 25821 INDUSTRIAL BOULEVARD
HAYWARD, CA 94545
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments51,63042,88666,137105,71560,46980,310113,464
Cash and cash equivalents12,66327,27414,68487,97552,90280,310107,922
Short-term investments38,96715,61251,45317,7407,567 5,542
Receivables1606355204011,5335,8333,286
Inventory, net of allowances, customer advances and progress billings1,1111,6263,2958549562,154466
Inventory1,1111,6263,2958549562,154466
Other undisclosed current assets2,5881,6831,7361,0244557561,731
Total current assets:55,48946,83071,688107,99463,41389,053118,947
Noncurrent Assets
Operating lease, right-of-use asset4,3023,1503,928
Nontrade receivables  263351   
Property, plant and equipment15,92815,65914,55211,48311,05110,7128,610
Restricted cash and investments   178178178178
Other noncurrent assets2,174656925527207  
Deferred tax assets, net 703  
Other undisclosed noncurrent assets     5050
Total noncurrent assets:22,40419,46519,66812,53912,13910,9408,838
TOTAL ASSETS:77,89366,29591,356120,53375,55299,993127,785
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,6457,6277,2486,6104,9676,1535,517
Accounts payable2,1212,7371,7202,0701,4241,5581,561
Accrued liabilities6,5244,8905,5284,5403,5434,5953,956
Deferred revenue 49300
Debt8,7968,7355,6008,6117,7272,9124,541
Deferred revenue and credits3623622,604
Other undisclosed current liabilities1,0681,224463707604764118
Total current liabilities:18,50917,63513,61115,92813,66010,19112,780
Noncurrent Liabilities
Long-term debt and lease obligation8,75715,74624,1573,38011,36918,63716,381
Long-term debt, excluding current maturities5,00713,14020,5173,38011,36918,63716,381
Operating lease, liability3,7502,6063,640
Liabilities, other than long-term debt1,2322993,5904163,8413,867838
Deferred revenue and credits3,8413,867838
Deferred revenue1,151 3,100
Deferred rent credit   416
Other liabilities81299490    
Other undisclosed noncurrent liabilities85,28888,36591,41696,55683,19172,63564,673
Total noncurrent liabilities:95,277104,410119,163100,35298,40195,13981,892
Total liabilities:113,786122,045132,774116,280112,061105,33094,672
Stockholders' equity
Stockholders' equity attributable to parent(35,893)(55,750)(41,418)4,253(36,509)(5,337)33,113
Common stock137987978514545
Additional paid in capital437,554382,637356,609349,194261,310240,977236,274
Accumulated other comprehensive income (loss)     3(1)
Accumulated deficit(473,584)(438,485)(398,106)(345,019)(297,870)(246,362)(203,205)
Total stockholders' equity:(35,893)(55,750)(41,418)4,253(36,509)(5,337)33,113
TOTAL LIABILITIES AND EQUITY:77,89366,29591,356120,53375,55299,993127,785

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues2,8185,4162,2892,1517,99517,35719,263
Revenue, net85210,9174,406
Sublease income199598596
Cost of revenue(4,275)(6,032)(6,806)(3,976)(369)(12,315)(1,770)
Cost of goods and services sold(3,753)(6,032)(6,806)(3,976)(369)(12,315)(1,770)
Gross profit:(1,457)(616)(4,517)(1,825)7,6265,04217,493
Operating expenses(34,508)(40,347)(49,688)(37,878)(46,677)(49,314)(39,217)
Other undisclosed operating income   3,97636912,3151,770
Operating loss:(35,965)(40,963)(54,205)(35,727)(38,682)(31,957)(19,954)
Nonoperating income (expense)871588968(11,420)(13,527)(11,234)(3,685)
Investment income, nonoperating1245832,1661,1385109181,720
Interest and debt expense(2,291)(3,305)(2,535)(2,217)(3,316)(2,770)(2,977)
Other undisclosed income from continuing operations before equity method investments, income taxes     2,7702,977
Loss from continuing operations before equity method investments, income taxes:(37,385)(43,680)(55,772)(49,364)(55,525)(43,191)(23,639)
Other undisclosed income from continuing operations before income taxes2,2913,3052,5352,2173,316  
Loss from continuing operations before income taxes:(35,094)(40,375)(53,237)(47,147)(52,209)(43,191)(23,639)
Income tax expense (benefit)(5)(4)(3)(2)70134(760)
Net loss available to common stockholders, basic:(35,099)(40,379)(53,240)(47,149)(51,508)(43,157)(24,399)
Other undisclosed net loss available to common stockholders, diluted      (2,120)
Net loss available to common stockholders, diluted:(35,099)(40,379)(53,240)(47,149)(51,508)(43,157)(26,519)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(35,099)(40,379)(53,240)(47,149)(51,508)(43,157)(24,399)
Comprehensive loss:(35,099)(40,379)(53,240)(47,149)(51,508)(43,157)(24,399)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    (3)43
Comprehensive loss, net of tax, attributable to parent:(35,099)(40,379)(53,240)(47,149)(51,511)(43,153)(24,396)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: